Updates from The Motley Fool

Latest updates on Esperion Therapeutics from  The Fool has written over 100 articles on Esperion Therapeutics.

Stock Performance

View Interactive ESPR Charts
Sponsored by

Key Data Points

Primary metrics and data points about Esperion Therapeutics.
Current Price: $45.54
Prev Close: $44.50
Open: $44.74
Bid: $23.03
Ask: $46.00
Day's Range: $44.32 - $45.66
52wk Range: $33.06 - $82.68
Volume: 367,124
Avg Vol 619,743
Market Cap: $1B
P/E (ttm): -6.63
EPS (ttm): -$6.71
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Esperion Therapeutics.
CAPS Rating 2 out of 5
64 Outperform
12 Underperform
CAPS All Stars
17 Outperform
3 Underperform

How do you think Esperion Therapeutics will perform against the market?

You pick for Esperion Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Tim Mayleben, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Esperion Therapeutics.


  • Exchange: NASDAQ